An international team, led by researchers at Nagoya University in Japan, may hav...
A Chinese biotechnology company’s experimental gene therapy has demonstrated enc...
In an unforeseen development, the FDA’s directive for a labeling alteration conc...
Novo Nordisk has announced its highest annual profit in decades, attributing it ...
Defender Pharmaceuticals, headquartered in St. Louis, faces a setback in its que...
It appears that Sarepta Therapeutics’ upcoming treatment for Duchenne muscular d...
A non-opioid pain reliever has demonstrated efficacy in two extensive clinical t...
Ferrer has announced that its FAB122 failed to achieve its primary efficacy and ...
Germany’s Federal Ministry of Health has published its evaluation report on the ...
In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gai...
Musk announced Neuralink's first sucessful human BCI implant on Sunday, but can ...
Astellas has submitted an sNDA in Japan seeking approval for PADCEV with KEYTRUD...
CMS’ CGT Access Model will see allow the agency to negotiate negotiate pricing a...
The FDA has granted an orphan drug designation to Revolo’s ‘1104, with plans for...
As the UK pharmaceutical sector adopts the VPAG scheme, the question of how this...
The NASA and US Navy-propelled company remains confident, with Defender CEO Barr...
